HMGB1 and intracranial hemorrhage: Similar neuroprotective effects of anti-HMGB1 mAbs have been reported in rodent models of ischemic brain injury, intracranial hemorrhage, and traumatic brain injury [15,16,17,18], as well as in a mouse model of spinal cord injury [44].